| Autor: |
Kesari S; Saint John's Cancer Institute at Providence Saint John's Health Center, Santa Monica, CA 90404, USA., Bessudo A; California Cancer Associates for Research & Excellence, San Diego, CA 92127, USA., Gastman BR; Department of Dermatology & Plastic Surgery, Cleveland Clinic, Cleveland, OH 44195, USA., Conley AP; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Villaflor VM; Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA 91010, USA., Nabell LM; Comprehensive Cancer Center, University of Alabama, Birmingham, AL 35205, USA., Madere D; Saint John's Cancer Institute at Providence Saint John's Health Center, Santa Monica, CA 90404, USA., Chacon E; Saint John's Cancer Institute at Providence Saint John's Health Center, Santa Monica, CA 90404, USA., Spencer C; California Cancer Associates for Research & Excellence, San Diego, CA 92127, USA., Li L; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Larson C; EpicentRx, Inc., La Jolla, CA 92037, USA., Reid T; EpicentRx, Inc., La Jolla, CA 92037, USA., Caroen S; EpicentRx, Inc., La Jolla, CA 92037, USA., Oronsky B; EpicentRx, Inc., La Jolla, CA 92037, USA., Stirn M; EpicentRx, Inc., La Jolla, CA 92037, USA., Williams J; EpicentRx, Inc., La Jolla, CA 92037, USA., Barve MA; Mary Crowley Cancer Research, Dallas, TX 75230, USA. |
